HIV drug
Jan 19 2008, Matt

Health-care products maker Johnson & Johnson won U.S. approval to sell a new HIV drug called Intelence for patients with resistance to other therapies, U.S. officials said Friday.

Stories
Most Recent Most Popular Most Commented
Currently this sections has no news, Please try Again Later or help us in building this section
You can Submit Newslinks HERE
Stories
Most Recent Most Popular Most Commented
Currently this sections has no news, Please try Again Later or help us in building this section
You can Submit Newslinks HERE